Elevate Uranium Stock Today
| ELVUF Stock | USD 0.17 0.01 5.56% |
Performance1 of 100
| Odds Of DistressOver 64
|
Elevate Uranium is trading at 0.17 as of the 4th of December 2024. This is a 5.56 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.17. Elevate Uranium has more than 64 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Elevate Uranium are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of November 2024 and ending today, the 4th of December 2024. Click here to learn more.
Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia. Elevate Uranium operates under Uranium classification in the United States and is traded on OTC Exchange. The company has 275.5 M outstanding shares. More on Elevate Uranium
Moving together with Elevate OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Elevate OTC Stock Highlights
| Business Concentration | Uranium, Energy (View all Sectors) |
Elevate Uranium [ELVUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 84.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elevate Uranium's market, we take the total number of its shares issued and multiply it by Elevate Uranium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Elevate Uranium classifies itself under Energy sector and is part of Uranium industry. The entity has 275.5 M outstanding shares.
Elevate Uranium has accumulated about 15.81 M in cash with (4.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06.
Check Elevate Uranium Probability Of Bankruptcy
Ownership AllocationElevate Uranium holds a total of 275.5 Million outstanding shares. Elevate Uranium shows 16.66 percent of its outstanding shares held by insiders and 10.13 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Elevate Ownership Details
Elevate Uranium Risk Profiles
| Mean Deviation | 5.42 | |||
| Semi Deviation | 6.42 | |||
| Standard Deviation | 8.81 | |||
| Variance | 77.7 |
Elevate Stock Against Markets
Picking the right benchmark for Elevate Uranium otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Elevate Uranium otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Elevate Uranium is critical whether you are bullish or bearish towards Elevate Uranium at a given time. Please also check how Elevate Uranium's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Elevate Uranium without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Elevate Uranium Corporate Management
Elected by the shareholders, the Elevate Uranium's board of directors comprises two types of representatives: Elevate Uranium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elevate. The board's role is to monitor Elevate Uranium's management team and ensure that shareholders' interests are well served. Elevate Uranium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elevate Uranium's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BBus FCIS | CFO Sec | Profile | |
| BSc PGeo | Consulting Geologist | Profile | |
| Berti Roesener | Consulting Namibia | Profile | |
| Fausimm BSc | CEO MD | Profile | |
| Jessica Bezuidenhout | Gen Namibia | Profile |
Other Information on Investing in Elevate OTC Stock
Elevate Uranium financial ratios help investors to determine whether Elevate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elevate with respect to the benefits of owning Elevate Uranium security.